Electron Paramagnetic Resonance Imaging (EPRI) may become a useful
tool for determining crucial oxygen levels in tumors and other
biological tissue.
Oxygen is central to many diseases; for example,
the absence of oxygen makes a cancer cell more resistant to
radiation and chemotherapy. Taking advantage of the properties of
electrons in certain biochemical compounds, Charles Pelizzari
(c-pelizzari@uchicago.edu) and his colleagues use a novel technique
to form images of the oxygen distribution in small animals with
millimeter spatial resolution. In a talk at the AAPM meeting,
Pelizzari's group will present EPR oxygen images superimposed on MRI
anatomical images of animals. Developing these tools at the Center
for In-Vivo EPR Imaging at the University of Chicago, the
researchers create these important maps of oxygen levels by
magnetically manipulating the unpaired electrons in certain
oxygen-containing molecules, including free radicals.
Most electrons
in atoms and molecules form pairs that mutually cancel out their
internal magnetic properties, but unpaired electrons can give the
atom/molecule “paramagnetic” properties that cause them to be weakly
attracted to an external magnetic field.
Electron paramagnetic resonance imaging (EPRI) obtains pictures of
molecules with unpaired electrons in a way that is similar to the
way MRI obtains images of atomic nuclei such as the hydrogen in
water: an image is formed when paramagnetic molecules, lined up in a
magnetic field, absorb and then re-emit electromagnetic waves in or
near the microwave portion of the spectrum. Using a series of
magnetic fields that vary in strength over a given region of space,
these emissions can be reconstructed into a 3D image.
Where EPRI is advantageous over MRI is in providing quantitative
images of the distribution of oxygen in living tissues. Pelizzari
expects that one day this EPR methodology will obtain
submillimeter-resolution maps and also be scaled up to human
dimensions. A potential long-term benefit of EPR imaging should be
in obtaining both maps of radiation-resistant tumor regions before
treatment and in providing quick feedback on the results of cancer
therapy in days or even hours, without the use of PET scans which
require radioactivity. (Meeting talk WE-D-I-609-8)